Analytical Testing Services News Today

Clinical Trials Market by Phase (Phase I, Phase II, Phase III, and Phase IV), by Design (Treatment Studies and Observational Studies), by Region – Global Share and Forecast to 2030

LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today announced a significant enhancement of its capabilities: a 50% expansion and an investment exceeding $2 million in its standalone offering for Analytical Testing Services (ATS) alongside the introduction of new suppository manufacturing capabilities to its contract development and manufacturing (CDMO) portfolio.

/PRNewswire/ -- The "Global Clinical Trials Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.coms offering. The clinical...

Dublin, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The

The Global Clinical Trials Market Size was valued at USD 51.24 billion in 2022 and the worldwide clinical trials market size is expected to reach USD 93.42...

With various trends and variables anticipated to fuel its growth in the upcoming years, the Asia Pacific Pharmaceutical Contract Development and

LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today reported strong growth in 2022 in both its long-established Active Pharmaceutical Ingredient (API) division and its new contract development and manufacturing (CDMO) division.

/PRNewswire/ -- The "Healthcare Analytical Testing Services - Global Strategic Business Report" report has been added to ResearchAndMarkets.coms offering....

Dublin, Feb. 07, 2023 (GLOBE NEWSWIRE) -- The "Healthcare Analytical Testing Services - Global Strategic Business Report" report has been added to ...

Read our PhD Diet Whey 2023 review to find out whether this protein powder really works for losing body fat while building lean muscle.